IBANDRONAT Mepha 150 mg comprimés mensuels

7680613170036 CH-61317 M05BA06 07.99.0.

Active substances:

IBANDRONAT Mepha 150 mg comprimés mensuels
IBANDRONAT Mepha 150 mg comprimés mensuels
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6131701
CPT
-
Packaging group
1
Unit
Tablette(n)
Composition
acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg.

Articles (1)

Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Filmtabletten
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
06/08/2026
Professional SmPC
Français
06/08/2026
Professional SmPC
Italien
06/08/2026
Patient information leaflet
Allemand
05/08/2026
Patient information leaflet
Français
05/08/2026
Patient information leaflet
Italien
05/08/2026

Detailed composition

Substance Quantity Type Category
acidum ibandronicum
150.0 MG Substance Wirkstoff (Principe actif)
natrii ibandronas monohydricus
- Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
povidonum
- Substance HNIDK
crospovidonum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
acidum stearicum
- Substance HNIDK
E 171
- Substance FNIDK
hypromellosum
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
polysorbatum 80
- Substance HNIDK
natrium
10.8 MG Substance HBESI

Reimbursement information

Public price
CHF 32.30
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2012

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
61317
Drug name
Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Galenic form
FILM
ATC Code
M05BA06
Authorization status
Z
Dispensation category
B
First authorization
24/02/2011
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
IBANDRONAT Mepha 150 mg comprimés mensuels
Description (DE)
IBANDRONAT Mepha 150 mg Monatstabletten
Market launch
24/02/2011
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
CHF 210.75
View original

Other packaging sizes

IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce
3 TABL
View
Buy us a coffee Explore the data